Entac Medical
Series B in 2020
Entac Medical is a healthcare company focused on developing innovative medical devices for predictive and diagnostic medicine through its unique audio spectral analysis technology. The company's flagship product, PrevisEA, is a Class II noninvasive and disposable device that has undergone clinical validation to predict the occurrence of postoperative ileus (POI) in surgical patients, a condition that affects 25% of patients within 2-6 days after surgery. By accurately predicting the risk of ileus, Entac Medical enhances treatment protocols and patient outcomes, while also reducing hospital readmissions and associated healthcare costs. The company aims to address significant unmet medical needs in postoperative care, enabling healthcare practitioners to better manage gastrointestinal complications and improve the overall surgical experience for patients.
Arkis BioSciences
Convertible Note in 2019
Arkis BioSciences Inc. specializes in the development and manufacturing of surgical tools and implantable devices aimed at treating conditions such as intracranial hypertension, traumatic brain injury, hemorrhagic stroke, and hydrocephalus. The company focuses on creating advanced catheters and minimally invasive instruments for neurosurgery, incorporating proprietary technologies like Endexo, which helps reduce complications associated with catheter use. Notable products include the Arkis Tunneling Guidewire, which streamlines ventriculoperitoneal shunt procedures, and anti-thrombogenic catheters designed to prevent obstructions. Founded in 2011 and based in Knoxville, Tennessee, Arkis BioSciences is dedicated to enhancing surgical techniques, thereby minimizing patient trauma, decreasing surgical times, and improving overall treatment outcomes. As of 2019, Arkis operates as a subsidiary of Integra LifeSciences Holdings Corporation.
Restore Medical Solutions
Venture Round in 2018
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Entac Medical
Series A in 2018
Entac Medical is a healthcare company focused on developing innovative medical devices for predictive and diagnostic medicine through its unique audio spectral analysis technology. The company's flagship product, PrevisEA, is a Class II noninvasive and disposable device that has undergone clinical validation to predict the occurrence of postoperative ileus (POI) in surgical patients, a condition that affects 25% of patients within 2-6 days after surgery. By accurately predicting the risk of ileus, Entac Medical enhances treatment protocols and patient outcomes, while also reducing hospital readmissions and associated healthcare costs. The company aims to address significant unmet medical needs in postoperative care, enabling healthcare practitioners to better manage gastrointestinal complications and improve the overall surgical experience for patients.
Arkis BioSciences
Venture Round in 2018
Arkis BioSciences Inc. specializes in the development and manufacturing of surgical tools and implantable devices aimed at treating conditions such as intracranial hypertension, traumatic brain injury, hemorrhagic stroke, and hydrocephalus. The company focuses on creating advanced catheters and minimally invasive instruments for neurosurgery, incorporating proprietary technologies like Endexo, which helps reduce complications associated with catheter use. Notable products include the Arkis Tunneling Guidewire, which streamlines ventriculoperitoneal shunt procedures, and anti-thrombogenic catheters designed to prevent obstructions. Founded in 2011 and based in Knoxville, Tennessee, Arkis BioSciences is dedicated to enhancing surgical techniques, thereby minimizing patient trauma, decreasing surgical times, and improving overall treatment outcomes. As of 2019, Arkis operates as a subsidiary of Integra LifeSciences Holdings Corporation.
Entac Medical
Series A in 2017
Entac Medical is a healthcare company focused on developing innovative medical devices for predictive and diagnostic medicine through its unique audio spectral analysis technology. The company's flagship product, PrevisEA, is a Class II noninvasive and disposable device that has undergone clinical validation to predict the occurrence of postoperative ileus (POI) in surgical patients, a condition that affects 25% of patients within 2-6 days after surgery. By accurately predicting the risk of ileus, Entac Medical enhances treatment protocols and patient outcomes, while also reducing hospital readmissions and associated healthcare costs. The company aims to address significant unmet medical needs in postoperative care, enabling healthcare practitioners to better manage gastrointestinal complications and improve the overall surgical experience for patients.
Arkis BioSciences
Convertible Note in 2017
Arkis BioSciences Inc. specializes in the development and manufacturing of surgical tools and implantable devices aimed at treating conditions such as intracranial hypertension, traumatic brain injury, hemorrhagic stroke, and hydrocephalus. The company focuses on creating advanced catheters and minimally invasive instruments for neurosurgery, incorporating proprietary technologies like Endexo, which helps reduce complications associated with catheter use. Notable products include the Arkis Tunneling Guidewire, which streamlines ventriculoperitoneal shunt procedures, and anti-thrombogenic catheters designed to prevent obstructions. Founded in 2011 and based in Knoxville, Tennessee, Arkis BioSciences is dedicated to enhancing surgical techniques, thereby minimizing patient trauma, decreasing surgical times, and improving overall treatment outcomes. As of 2019, Arkis operates as a subsidiary of Integra LifeSciences Holdings Corporation.
Restore Medical Solutions
Debt Financing in 2017
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Arkis BioSciences
Venture Round in 2017
Arkis BioSciences Inc. specializes in the development and manufacturing of surgical tools and implantable devices aimed at treating conditions such as intracranial hypertension, traumatic brain injury, hemorrhagic stroke, and hydrocephalus. The company focuses on creating advanced catheters and minimally invasive instruments for neurosurgery, incorporating proprietary technologies like Endexo, which helps reduce complications associated with catheter use. Notable products include the Arkis Tunneling Guidewire, which streamlines ventriculoperitoneal shunt procedures, and anti-thrombogenic catheters designed to prevent obstructions. Founded in 2011 and based in Knoxville, Tennessee, Arkis BioSciences is dedicated to enhancing surgical techniques, thereby minimizing patient trauma, decreasing surgical times, and improving overall treatment outcomes. As of 2019, Arkis operates as a subsidiary of Integra LifeSciences Holdings Corporation.
Restore Medical Solutions
Debt Financing in 2016
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Arkis BioSciences
Series A in 2016
Arkis BioSciences Inc. specializes in the development and manufacturing of surgical tools and implantable devices aimed at treating conditions such as intracranial hypertension, traumatic brain injury, hemorrhagic stroke, and hydrocephalus. The company focuses on creating advanced catheters and minimally invasive instruments for neurosurgery, incorporating proprietary technologies like Endexo, which helps reduce complications associated with catheter use. Notable products include the Arkis Tunneling Guidewire, which streamlines ventriculoperitoneal shunt procedures, and anti-thrombogenic catheters designed to prevent obstructions. Founded in 2011 and based in Knoxville, Tennessee, Arkis BioSciences is dedicated to enhancing surgical techniques, thereby minimizing patient trauma, decreasing surgical times, and improving overall treatment outcomes. As of 2019, Arkis operates as a subsidiary of Integra LifeSciences Holdings Corporation.
RistCall
Seed Round in 2016
RistCall is a company that develops smartwatch devices aimed at enhancing patient safety and satisfaction in healthcare settings, particularly hospitals and senior care communities. By replacing traditional call bell systems with their innovative wearable technology, RistCall facilitates improved communication between patients and nursing staff. This approach not only helps to reduce the incidence of falls but also enhances overall patient satisfaction, as measured by HCAHPS scores. Through its focus on wearable technology, RistCall addresses critical needs in patient care, ensuring a safer and more responsive healthcare environment.
Entac Medical
Series A in 2016
Entac Medical is a healthcare company focused on developing innovative medical devices for predictive and diagnostic medicine through its unique audio spectral analysis technology. The company's flagship product, PrevisEA, is a Class II noninvasive and disposable device that has undergone clinical validation to predict the occurrence of postoperative ileus (POI) in surgical patients, a condition that affects 25% of patients within 2-6 days after surgery. By accurately predicting the risk of ileus, Entac Medical enhances treatment protocols and patient outcomes, while also reducing hospital readmissions and associated healthcare costs. The company aims to address significant unmet medical needs in postoperative care, enabling healthcare practitioners to better manage gastrointestinal complications and improve the overall surgical experience for patients.
Entac Medical
Seed Round in 2015
Entac Medical is a healthcare company focused on developing innovative medical devices for predictive and diagnostic medicine through its unique audio spectral analysis technology. The company's flagship product, PrevisEA, is a Class II noninvasive and disposable device that has undergone clinical validation to predict the occurrence of postoperative ileus (POI) in surgical patients, a condition that affects 25% of patients within 2-6 days after surgery. By accurately predicting the risk of ileus, Entac Medical enhances treatment protocols and patient outcomes, while also reducing hospital readmissions and associated healthcare costs. The company aims to address significant unmet medical needs in postoperative care, enabling healthcare practitioners to better manage gastrointestinal complications and improve the overall surgical experience for patients.
Restore Medical Solutions
Series A in 2015
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Restore Medical Solutions
Venture Round in 2014
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
S2 Interactive
Venture Round in 2014
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
S2 Interactive
Convertible Note in 2014
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
Restore Medical Solutions
Series A in 2014
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Mobilizer
Seed Round in 2014
Mobilizer Inc. is a company focused on enhancing medical ambulation through its innovative design of a six-wheeled holster for medical equipment. Modeled after a wheeled walker, this holster features shelves and attachments that facilitate the safe and efficient transport of equipment for critical care patients. By streamlining the ambulation process, Mobilizer aims to improve patient well-being and increase operational efficiency within healthcare settings. The company emerged from the ZeroTo510 medical device startup accelerator, reflecting its commitment to advancing medical technology solutions.
S2 Interactive
Debt Financing in 2013
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
Restore Medical Solutions
Venture Round in 2013
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Mobilizer
Seed Round in 2013
Mobilizer Inc. is a company focused on enhancing medical ambulation through its innovative design of a six-wheeled holster for medical equipment. Modeled after a wheeled walker, this holster features shelves and attachments that facilitate the safe and efficient transport of equipment for critical care patients. By streamlining the ambulation process, Mobilizer aims to improve patient well-being and increase operational efficiency within healthcare settings. The company emerged from the ZeroTo510 medical device startup accelerator, reflecting its commitment to advancing medical technology solutions.
BioNanovations
Seed Round in 2013
BioNanovations is a medical device company based in the United States, specializing in the development of a handheld diagnostic platform that utilizes bionanotechnology to identify bacterial infections, specifically Staphylococcus infections. The company aims to significantly reduce the diagnostic time from the current 3-5 days to under 30 minutes, addressing the urgent need for timely diagnosis due to the potential severity of aggressive strains that can lead to serious health complications. The platform is designed to monitor various biological samples, including blood, sputum, urine, and cerebrospinal fluid, providing healthcare professionals with immediate access to diagnostic information. This innovation not only enhances patient care by improving diagnostic efficiency but also facilitates the transmission of epidemiological data, enabling better tracking of infection trends. BioNanovations targets hospitals, healthcare providers, and government agencies, ultimately striving to improve patient outcomes by reducing morbidity and mortality associated with bacterial infections.
Mobilizer
Seed Round in 2013
Mobilizer Inc. is a company focused on enhancing medical ambulation through its innovative design of a six-wheeled holster for medical equipment. Modeled after a wheeled walker, this holster features shelves and attachments that facilitate the safe and efficient transport of equipment for critical care patients. By streamlining the ambulation process, Mobilizer aims to improve patient well-being and increase operational efficiency within healthcare settings. The company emerged from the ZeroTo510 medical device startup accelerator, reflecting its commitment to advancing medical technology solutions.
S2 Interactive
Seed Round in 2013
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
Restore Medical Solutions
Series A in 2012
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Restore Medical Solutions
Convertible Note in 2012
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
Restore Medical Solutions
Debt Financing in 2012
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
BioNanovations
Seed Round in 2012
BioNanovations is a medical device company based in the United States, specializing in the development of a handheld diagnostic platform that utilizes bionanotechnology to identify bacterial infections, specifically Staphylococcus infections. The company aims to significantly reduce the diagnostic time from the current 3-5 days to under 30 minutes, addressing the urgent need for timely diagnosis due to the potential severity of aggressive strains that can lead to serious health complications. The platform is designed to monitor various biological samples, including blood, sputum, urine, and cerebrospinal fluid, providing healthcare professionals with immediate access to diagnostic information. This innovation not only enhances patient care by improving diagnostic efficiency but also facilitates the transmission of epidemiological data, enabling better tracking of infection trends. BioNanovations targets hospitals, healthcare providers, and government agencies, ultimately striving to improve patient outcomes by reducing morbidity and mortality associated with bacterial infections.
S2 Interactive
Convertible Note in 2012
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
S2 Interactive
Seed Round in 2012
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.
Restore Medical Solutions
Seed Round in 2012
Restore Medical Solutions, Inc., established in 2012 and based in Memphis, Tennessee, specializes in manufacturing modular sterilization tray systems for hospitals and surgery centers. Their products aim to reduce surgical site infections (SSIs), enhance safety, and improve productivity within the healthcare industry by minimizing the risk of contamination from medical instruments.
BioNanovations
Seed Round in 2012
BioNanovations is a medical device company based in the United States, specializing in the development of a handheld diagnostic platform that utilizes bionanotechnology to identify bacterial infections, specifically Staphylococcus infections. The company aims to significantly reduce the diagnostic time from the current 3-5 days to under 30 minutes, addressing the urgent need for timely diagnosis due to the potential severity of aggressive strains that can lead to serious health complications. The platform is designed to monitor various biological samples, including blood, sputum, urine, and cerebrospinal fluid, providing healthcare professionals with immediate access to diagnostic information. This innovation not only enhances patient care by improving diagnostic efficiency but also facilitates the transmission of epidemiological data, enabling better tracking of infection trends. BioNanovations targets hospitals, healthcare providers, and government agencies, ultimately striving to improve patient outcomes by reducing morbidity and mortality associated with bacterial infections.
S2 Interactive
Debt Financing in 2011
S2 Interactive, Inc. is a Delaware C corp. founded by Larry Foster, R.N., in September, 2011. After working as a surgical nurse and spending 26 years in leadership roles within sales, marketing and professional education in the orthopedic & spine industry, Larry was convinced there was an opportunity to teach hospital staff to learn and manage surgical instruments more efficiently and safely. Larry spent five years working with technology experts realizing with the current trends in healthcare there was a clear need to increase hospital staff productivity/efficiency while driving cost savings. Larry’s vision combined with the introduction of user-friendly “hand held” technology platforms (tablets) enabled S2 Interactive to develop Virtual Back Table and Tray Touch software platforms. In September, 2011 additional funding was provided by 2 Memphis based venture capital organizations, Innova & MB Ventures. They are proud to be working with market leading companies in Medical Devices and many of the nation’s most prominent hospitals. Their technology has been used by over 1,000 different users in a variety of surgical specialties including cardiology, orthopedics, spine , general surgery and trauma.